295 related articles for article (PubMed ID: 34209175)
21. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma.
Yang DS; Smith JD; Zhou Z; Gandy SE; Martins RN
J Neurochem; 1997 Feb; 68(2):721-5. PubMed ID: 9003062
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein E isoform-dependent effects on the processing of Alzheimer's amyloid-β.
Chai AB; Lam HHJ; Kockx M; Gelissen IC
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Sep; 1866(9):158980. PubMed ID: 34044125
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
Baum L; Chen L; Ng HK; Pang CP
Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
[TBL] [Abstract][Full Text] [Related]
24. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
[TBL] [Abstract][Full Text] [Related]
25. Human apolipoprotein E isoforms are differentially sialylated and the sialic acid moiety in ApoE2 attenuates ApoE2-Aβ interaction and Aβ fibrillation.
Moon HJ; Haroutunian V; Zhao L
Neurobiol Dis; 2022 Mar; 164():105631. PubMed ID: 35041991
[TBL] [Abstract][Full Text] [Related]
26. Opposing Effects of ApoE2 and ApoE4 on Glycolytic Metabolism in Neuronal Aging Supports a Warburg Neuroprotective Cascade against Alzheimer's Disease.
Zhang X; Wu L; Swerdlow RH; Zhao L
Cells; 2023 Jan; 12(3):. PubMed ID: 36766752
[TBL] [Abstract][Full Text] [Related]
27. Human apolipoprotein E2 promotes parenchymal amyloid deposition and neuronal loss in vasculotropic mutant amyloid-β protein Tg-SwDI mice.
Xu F; Vitek MP; Colton CA; Previti ML; Davis J; Van Nostrand WE
J Alzheimers Dis; 2012; 31(2):359-69. PubMed ID: 22635103
[TBL] [Abstract][Full Text] [Related]
28. Chemical cross-linking/mass spectrometry maps the amyloid β peptide binding region on both apolipoprotein E domains.
Deroo S; Stengel F; Mohammadi A; Henry N; Hubin E; Krammer EM; Aebersold R; Raussens V
ACS Chem Biol; 2015 Apr; 10(4):1010-6. PubMed ID: 25546376
[TBL] [Abstract][Full Text] [Related]
29. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
[TBL] [Abstract][Full Text] [Related]
30. Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk.
Tai LM; Mehra S; Shete V; Estus S; Rebeck GW; Bu G; LaDu MJ
Mol Neurodegener; 2014 Jan; 9():2. PubMed ID: 24386905
[TBL] [Abstract][Full Text] [Related]
31. Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides.
Tokuda T; Calero M; Matsubara E; Vidal R; Kumar A; Permanne B; Zlokovic B; Smith JD; Ladu MJ; Rostagno A; Frangione B; Ghiso J
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):359-65. PubMed ID: 10816430
[TBL] [Abstract][Full Text] [Related]
32. Isoform-specific effect of apolipoprotein E on endocytosis of beta-amyloid in cultures of neuroblastoma cells.
Yamauchi K; Tozuka M; Hidaka H; Nakabayashi T; Sugano M; Katsuyama T
Ann Clin Lab Sci; 2002; 32(1):65-74. PubMed ID: 11848621
[TBL] [Abstract][Full Text] [Related]
33. Electrochemical detection of specific interactions between apolipoprotein E isoforms and DNA sequences related to Alzheimer's disease.
Lima D; Hacke ACM; Inaba J; Pessôa CA; Kerman K
Bioelectrochemistry; 2020 Jun; 133():107447. PubMed ID: 32006858
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
Marais AD
Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease.
Dorey E; Chang N; Liu QY; Yang Z; Zhang W
Neurosci Bull; 2014 Apr; 30(2):317-30. PubMed ID: 24652457
[TBL] [Abstract][Full Text] [Related]
36. Reduced binding of apoE4 to complement factor H promotes amyloid-β oligomerization and neuroinflammation.
Chernyaeva L; Ratti G; Teirilä L; Fudo S; Rankka U; Pelkonen A; Korhonen P; Leskinen K; Keskitalo S; Salokas K; Gkolfinopoulou C; Crompton KE; Javanainen M; Happonen L; Varjosalo M; Malm T; Leinonen V; Chroni A; Saavalainen P; Meri S; Kajander T; Wollman AJ; Nissilä E; Haapasalo K
EMBO Rep; 2023 Jul; 24(7):e56467. PubMed ID: 37155564
[TBL] [Abstract][Full Text] [Related]
37. High ability of apolipoprotein E4 to stabilize amyloid-β peptide oligomers, the pathological entities responsible for Alzheimer's disease.
Cerf E; Gustot A; Goormaghtigh E; Ruysschaert JM; Raussens V
FASEB J; 2011 May; 25(5):1585-95. PubMed ID: 21266538
[TBL] [Abstract][Full Text] [Related]
38. Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation.
Cho HS; Hyman BT; Greenberg SM; Rebeck GW
J Neuropathol Exp Neurol; 2001 Apr; 60(4):342-9. PubMed ID: 11305869
[TBL] [Abstract][Full Text] [Related]
39. ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function.
Manelli AM; Stine WB; Van Eldik LJ; LaDu MJ
J Mol Neurosci; 2004; 23(3):235-46. PubMed ID: 15181252
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein E Interferes with IAPP Aggregation and Protects Pericytes from IAPP-Induced Toxicity.
Gharibyan AL; Islam T; Pettersson N; Golchin SA; Lundgren J; Johansson G; Genot M; Schultz N; Wennström M; Olofsson A
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
